BCG found GLP-1 users plan to spend 11% more on high-protein food, while Reuters found brands inflating protein claims with bigger serving sizes.
Recap by typeshit. Full story at European Supermarket Magazine.
The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
An industry piece on the production challenges facing ADCs, bispecifics, peptides and other newer drug types, and how makers are solving them.
In an ANI broadcast promo, Batra says users may lose muscle mass and calls keto unsustainable over the long term.
Loading…